Harith Rajagopalan - 10 Nov 2024 Form 4 Insider Report for FRACTYL HEALTH, INC. (GUTS)

Role
Chief Executive Officer, Director
Signature
/s/ Lisa A. Davidson, Attorney-in-fact
Issuer symbol
GUTS
Transactions as of
10 Nov 2024
Net transactions value
-$238,358
Form type
4
Filing time
13 Nov 2024, 18:26:12 UTC
Previous filing
08 Feb 2024
Next filing
03 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GUTS Common Stock Options Exercise $0 +216,924 +58% $0.000000 587,846 10 Nov 2024 Direct F1
transaction GUTS Common Stock Sale $238,358 -96,517 -16% $2.47 491,329 11 Nov 2024 Direct F2
holding GUTS Common Stock 292,171 10 Nov 2024 By 2021 Irrevocable Trust
holding GUTS Common Stock 292,170 10 Nov 2024 By 2016 Irrevocable Trust
holding GUTS Common Stock 18,639 10 Nov 2024 By 2021 Family Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GUTS Restricted Stock Units Options Exercise $0 -216,924 -100% $0.000000 0 10 Nov 2024 Common Stock 216,924 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vested in full on November 10, 2024 and have no expiration date.
F2 Represents shares sold for tax-withholding purposes due upon the vesting of the restricted stock units.